Responses
Basic and translational research
Extended report
Prostaglandin I2 analogues enhance already exuberant Th17 cell responses in systemic sclerosis
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016PGI2-induced Th17 cells differentiation in connective tissue disease: a commentShow More
Dear Editor
We read with interest the study conducted by Truchetet and colleagues on the regulation of PGI2 in Th17 cells differentiation in systemic sclerosis (SSc). Actually, previous in vitro studies have found that synthetic PGI2 enhanced Th17 cells differentiation1. Zhou et al2 has also demonstrated that PGI2 induced Th17 cells differentiation through modulating the ratio of IL-23/IL-12 in a mouse model of experim...
Conflict of Interest:
None declared.